Production (Stage)
MiNK Therapeutics, Inc.
INKT
$7.26
-$0.035-0.48%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.77M | -2.46M | -1.81M | -2.70M | -3.81M |
| Total Depreciation and Amortization | 50.80K | 53.90K | 62.60K | 45.10K | 53.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 784.00K | 703.00K | -1.19M | 445.70K | 596.50K |
| Change in Net Operating Assets | 591.00K | -21.40K | -60.00K | -79.60K | 620.80K |
| Cash from Operations | -1.34M | -1.73M | -2.99M | -2.29M | -2.54M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 0.00 | 0.00 | 0.00 | 5.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 600.00 | -- | 6.80K | 5.81M | 6.90K |
| Repurchase of Common Stock | -- | 0.00 | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 600.00 | 0.00 | 6.80K | 5.81M | 5.01M |
| Foreign Exchange rate Adjustments | -1.80K | -23.50K | 2.70K | -19.00K | -14.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.34M | -1.75M | -2.99M | 3.50M | 2.45M |